Get the Stockscreener App
20.64
0.34%
-0.07
After Hours:
20.67
0.03
+0.15%
Abrdn Life Sciences Investors stock is traded at $20.64, with a volume of 110.75K.
It is down -0.34% in the last 24 hours and up +4.77% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
See More
Previous Close:
$20.71
Open:
$20.76
24h Volume:
110.75K
Relative Volume:
0.76
Market Cap:
$627.62M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.53%
1M Performance:
+4.77%
6M Performance:
+26.32%
1Y Performance:
+46.28%
1-Day Range:
$20.48
$20.76
1-Week Range:
$20.42
$21.43
52-Week Range:
$13.88
$22.67
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL vs DNP, UTG, ADX, UTF, GDV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
20.64 | 671.41M | 0 | 0 | 0 | 0.00 |
DNP
Dnp Select Income Fund Inc
|
10.74 | 4.17B | 0 | 0 | 0 | 0.00 |
UTG
Reaves Utility Income Fund
|
38.30 | 3.56B | 0 | 0 | 0 | 0.00 |
ADX
Adams Diversified Equity Fund
|
26.13 | 3.23B | 0 | 0 | 0 | 0.00 |
UTF
Cohen Steers Infrastructure Fund Inc
|
26.78 | 3.03B | 0 | 0 | 0 | 0.00 |
GDV
Gabelli Dividend Income Trust
|
29.98 | 2.64B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
Abrdn Life Sciences Investors To Go Ex-Dividend On August 24th, 2026 With 0.62 USD Dividend Per Share - Moomoo
abrdn Healthcare Investors (NYSE:HQH) Sets New 12-Month HighStill a Buy? - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Hits New 12-Month HighHere's What Happened - MarketBeat
abrdn Life Sciences Investors (HQL) Gains 1.28% to $21.37 as Life Sciences Sentiment StrengthensInstitutional Sentiment - vinanet.vn
abrdn Healthcare Investors (HQH) Slips 1.14% as Shares Test Key Trading RangeSector ETF Flow - vinanet.vn
abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update - MarketBeat
abrdn Life Sciences Investors Q2 2026 Commentary - Seeking Alpha
abrdn Life Sciences Investors (HQL) Advances 0.52% as Life Sciences Sector Holds SteadyHull Moving Average - vinanet.vn
abrdn Healthcare Opportunities Fund (THQ) Declares Monthly Divid - GuruFocus
abrdn U.S. Closed-End Funds announce August-Sep... - Pluang
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts - Morningstar
abrdn Healthcare Investors (HQH) Edges Higher as Defensive Positioning Supports PricePCR Spike - vinanet.vn
abrdn Life Sciences Investors (HQL) Posts 1.56% Gain as Healthcare Sector Momentum BuildsZigzag Correction - vinanet.vn
Price to earnings forward of abrdn Healthcare Investors Shares of Beneficial Interest – BOATS:HQH - TradingView
abrdn Healthcare Investors (HQH) Slips 0.77% as Shares Hold Above Key SupportDouble Bottom - vinanet.vn
Saba Capital Management L.P. Sells 1,169,828 Shares of abrdn Life Sciences Investors $HQL - MarketBeat
abrdn Life Sciences Investors (HQL) Edges Higher Amid Sector ResilienceNegative Gamma - dars.gov.et
Short Interest in abrdn Life Sciences Investors (NYSE:HQL) Grows By 339.8% - MarketBeat
Price to sales forward of abrdn Healthcare Investors Shares of Beneficial Interest – NYSE:HQH - TradingView
Price to earnings forward of abrdn Healthcare Investors Shares of Beneficial Interest – NYSE:HQH - TradingView
abrdn Life Sciences Investors Shares of Beneficial Interest Revenue Breakdown – NYSE:HQL - TradingView
abrdn Life Sciences Investors (NYSE:HQL) Sees Large Volume IncreaseHere's Why - MarketBeat
abrdn Healthcare Investors (NYSE:HQH) Sees Strong Trading VolumeHere's Why - MarketBeat
Allspring Global Investments Holdings LLC Grows Position in abrdn Life Sciences Investors $HQL - MarketBeat
Director Chris Mahai Acquires Shares in abrdn Healthcare Investo - GuruFocus
Insider Buying: Chris Mahai Acquires Shares of abrdn Life Sciences Investors (HQL) - GuruFocus
Director Chris Mahai buys 527 abrdn Life Sciences (NYSE: HQL) shares - Stock Titan
abrdn Life Sciences Investors (HQL) Slips 2.08% as Support Levels LoomValue Factor - vinanet.vn
abrdn Life Sciences Investors (NYSE:HQL) Hits New 52-Week HighStill a Buy? - MarketBeat
NYSE New 52-Week Highs And Lows - Moomoo
Fed Minutes Reveal Significant Disagreement on Interest Rate PathReturn On Equity - Bölüm Sonu Canavarı
abrdn Life Sciences Investors (HQL) Rallies 2.38% as Sector Sentiment ImprovesDividend Arbitrage - dars.gov.et
HQL Edges Higher: abrdn Life Sciences Investors Shares Climb 0.70%Volatility Term Structure - dars.gov.et
THWabrdn World Healthcare Fund Website Traffic and Mobile Apps Usage - Finviz
abrdn Healthcare Opportunities Fund offers high... - Pluang
THQ: A Solid Healthcare Fund For 2026 (NYSE:THQ) - Seeking Alpha
Press Release: Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - Moomoo
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - TradingView
abrdn Life Sciences Investors (HQL) Advances 0.83% as Life Sciences Sector Shows StrengthMFI Divergence - dars.gov.et
abrdn Healthcare Investors (HQH) Edges Higher: Testing Key Resistance Near $20.50Volatility Breakout Picks - newsline.com
abrdn Healthcare Investors (HQH) Advances 1.44% as Sector Fund Tests Key Resistance ZoneHidden Order - newsline.com
abrdn Healthcare Opportunities Fund (THQ) Edges Higher Amid Sector StabilityGap and Go - newsline.com
New abrdn Life Sciences (NYSE: HQL) director files initial Form 3 - Stock Titan
Mahai Chris LaVictoire joins abrdn Healthcare (HQH) as reporting insider - Stock Titan
abrdn Healthcare Opportunities Fund (THQ) Announces $0.18 Monthl - GuruFocus
Abrdn Life Sciences Investors Reports Earnings Results for the Half Year Ended March 31, 2026 - marketscreener.com
Abrdn Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2026 - marketscreener.com
abrdn Healthcare Investors (HQH) Dips 2.74% as Sector Rotation Pressures the Closed-End FundKAMA Signal - dars.gov.et
HQHabrdn Healthcare Investors Stock Price and Quote - Finviz
THQabrdn Healthcare Opportunities Fund Stock Price and Quote - Finviz
THQ Surges 1.69%: Healthcare Fund Breaks Above Key Support LevelsFactor Valuation - newsline.com
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Abrdn Life Sciences Investors Stock (HQL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pittard Christian | Director |
Dec 16 '25 |
Buy |
16.88 |
7,923 |
133,755 |
7,923 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 22 '25 |
Sale |
14.14 |
41,623 |
588,549 |
2,837,633 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 19 '25 |
Sale |
14.10 |
6,989 |
98,545 |
2,879,256 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 18 '25 |
Sale |
14.07 |
40,208 |
565,727 |
2,886,245 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 17 '25 |
Sale |
13.99 |
24,328 |
340,349 |
2,926,453 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 16 '25 |
Sale |
13.99 |
2,026 |
28,344 |
2,950,781 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 15 '25 |
Sale |
14.13 |
700 |
9,891 |
2,952,807 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 11 '25 |
Sale |
14.28 |
15,116 |
215,856 |
2,953,507 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 02 '25 |
Sale |
14.04 |
14,083 |
197,725 |
2,968,623 |
0.28%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):